Aurobindo Pharma Gets FTC Nod For $250 Million Lannett Acquisition
Deal Strengthens US Manufacturing And Expands Complex Generics Portfolio Aurobindo Pharma has received approval from the US Federal Trade Commission (FTC) for its proposed $250 million acquisition of Lannett Company LLC through its subsidiary, Aurobindo Pharma USA, Inc. According to a regulatory filing, the transaction is valued at $250 million on a cash-free, debt-free basis, […]